Biosino Bio-Technology and Science Incorporation (HKG:8247)

Market Cap	619.35M +470.7%
Revenue (ttm)	246.61M -20.7%
Net Income	-51.86M
EPS	-0.36
Shares Out	144.71M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	574,000
Average Volume	1,134,965
Open	4.120
Previous Close	4.090
Day's Range	4.030 - 4.340
52-Week Range	0.260 - 7.000
Beta	-0.53
RSI	53.54
Earnings Date	Mar 30, 2026

About HKG:8247

Biosino Bio-Technology and Science Incorporation, together with its subsidiaries, manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China. The company offers clinical chemistry reagents, including single and double reagents, calibrators, QC products, and washing solution detergents; Elisa kits; rapid tests; and analyzers. It also provides medical and medical inspection services; and produces and sells medical instruments. Biosino Bio-Technology and Science Incorporation founded in 1988 and is based in Beijing, the Pe...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1988
• Employees: 471
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8247

Financial Performance

In 2024, HKG:8247's revenue was 263.07 million, a decrease of -9.00% compared to the previous year's 289.07 million. Losses were -42.53 million, 265.1% more than in 2023.

Financial numbers in CNY